No Detail Found!

Effects of palonosetron and ramosetron mixed with intravenous patient-controlled analgesia infusion fluid after preoperative single injection of palonosetron for the prevention of postoperative nausea and vomiting

Author(s)
Yei Heum Park Department of Anesthesiology and Pain Medicine, Haeundae Paik Hospital of Inje University,Haeundae-gu,Republic of Korea
Yukyung Jeon Department of Anesthesiology and Pain Medicine, Haeundae Paik Hospital of Inje University,Haeundae-gu,Republic of Korea
Jae-Wook Jung Department of Anesthesiology and Pain Medicine, Haeundae Paik Hospital of Inje University,Haeundae-gu,Republic of Korea
Hyojoong Kim Department of Anesthesiology and Pain Medicine, Haeundae Paik Hospital of Inje University,Haeundae-gu,Republic of Korea
Daeseok Oh Department of Anesthesiology and Pain Medicine, Haeundae Paik Hospital of Inje University,Haeundae-gu,Republic of Korea
Myoung Jin Ko Department of Anesthesiology and Pain Medicine, Haeundae Paik Hospital of Inje University,Haeundae-gu,Republic of Korea
Abstract
Objective: To evaluate the effects of the antiemetic drugs palonosetron and ramosetron, mixed with opioid-based intravenous patientcontrolled analgesia (IV-PCA) regimen on postoperative nausea and vomiting (PONV). Methodology: Patients were randomly allocated to three groups. Palonosetron (0.075 mg) was administered intravenously to all patients before anesthetic induction, and a 100-ml IV-PCA infusion, which contained 20 mcg/kg of fentanyl with placebo (normal saline) in group 1, ramosetron (0.3 mg) in group 2, and palonosetron (0.075 mg) in group 3 was started at the end of surgery. PONV, postoperative pain, and adverse effects were assessed. Results: The incidence of postoperative nausea at PACU was lower in group 2 than in group 1 (5.6% vs 33.3%, p<0.05). Postoperative nausea scores at PACU and 6 h after discharge from PACU were significantly lower in group 2 and group 3 than in group 1. The requirement of rescue antiemetics was higher in group 1 than in other groups (p=0.004). There were no differences in the incidence and severity of PONV between ramosetron and palonosetron groups. Conclusion: Infusion of palonosetron or ramosetron with the IV-PCA regimen may help to prevent PONV effectively. However, there was no difference between the effect of palonosetron and ramosetron. 
Publication Details
Page(s) 554-559
DOI DOI not available
Published Journal: Rawal Medical Journal, Volume: 46, Issue: 3, Year: 2021

Request the full text from PASTIC

Keywords
intravenous patient-controlled analgesia, opioid, 5-HT receptor antagonist
0

Citations

0

Downloads

34

Views